Also, we speculate that targeting Brd4 with inhibitors is more likely to eliminate tumor cells in “cold tumor” defined as the lack of immune cell infiltration, while “hot tumor,” defined as with relative abundant immune cells infiltration may not respond well to Brd4 inhibition, as targeting Brd4 simultaneously acts on tumor cells and CD8+ T cells. Here, CD8A is linked to neoplasm.